Anika Wuestefeld, PhD
@WuestefeldAnika
Followers
368
Following
518
Media
3
Statuses
70
Postdoc | Lund University | @biofinder_study | Neuroimaging | Neuroscience | Neuropsychology | Aging & neurodegenerative diseases
Lund, Sverige
Joined October 2020
Really happy that the final paper of my PhD is out now! It was great to work on this project with Dave Wolk & Laura Wisse and all others involved! See below for more information! 👇
🚨Publication alert: This study led by @WuestefeldAnika aims to provide a more granular understanding of how tau pathology leads to specific cognitive decline in Alzheimer's disease. 🧠Out now in Alzheimer’s & Dementia! Read it here: https://t.co/ub40f41PpJ 🧵👇
0
0
9
ISTAART members: Public comment is open on a draft guideline for cognitive assessment in adults 55+ in primary care. Your input can help shape this important resource. Deadline: July 11, 5 p.m. CDT Review:Â https://t.co/iXl3COR2y4
#Alzsky #AlzResearch
0
5
8
Dear Scientist/Researcher, Please help us understand reasons behind disparities in publication and citation practices in the Alzheimer’s Disease and Related Dementias field. Please fill out this short 5-min survey by April 18, 2025. Link below👇 https://t.co/Luf5HroY2f Thank you!
2
6
6
Another great webinar is in the pipeline: Join us and our speakers @anne_maass & Graziella Donatelli for insights into "Ultra-High Field MRI in Neurodegenerative Diseases" 📅Date: April 14 - 10:00 am CT 💻Register here: https://t.co/5mBbPPQiEx
@ISTAART
1
2
6
Highly recommended!!
Thrilled to be back home at @BarcelonaBeta as the Lead of the Neuroimaging Group! 🎉 Even better, we have a PhD position open to work with PET & MRI imaging in early stages of #Alzheimer’s. If you know someone passionate about neuroimaging, please share👇
0
0
2
Join us for a @NeuroimagingPIA @ISTAART Journal Club! 📅Date: 8th November - 11am US Eastern Time 💻Register here: https://t.co/TDRFbcDCbn
1
5
14
🚨New publication led by @WuestefeldAnika published in @AlzheimersRes We find that medial temporal lobe atrophy patterns in *amnestic* early-onset Alzheimer's disease are similar to those of amnestic late-onset AD and show similar levels of co-pathologies. https://t.co/yOGhtNVQ3B
alzres.biomedcentral.com
Background The medial temporal lobe (MTL) is hypothesized to be relatively spared in early-onset Alzheimer’s disease (EOAD). Yet, detailed examination of MTL subfields and drivers of atrophy in...
1
15
20
Interested in combining neuroimaging and multiomics in AD? Check out our new review on this topic, just published in Cell Reports Medicine. We focus on integration with amyloid- and tau-PET and all the challenges that come with it. w/ @NiklasMattsson4
https://t.co/Yv79AsmCsy
1
25
57
Don't forget: Tomorrow, September 12, 10-11am CDT, is the Neuroimaging PIA all members business meeting! Sign up to hear about all 2023-2024 NPIA achievements and plans for the next year. Register here: https://t.co/hFBk6kcoAc This session will not be recorded.
1
6
8
🚨Publication in @JAMA_current 🚨 Blood biomarkers to detect Alzheimer’s disease in primary and secondary care, published today in JAMA led by @SebastianPalmqv:
jamanetwork.com
This prospective study evaluates a clinically available Alzheimer disease blood test in primary and secondary care using predefined biomarker cutoff values.
2
21
56
#AAIC24 here we go! Ready for a week of good science in Philadelphia 🔔 We start with @NeuroimagingPIA and PIA day. Our group has already some results presented today as presentations and posters. Don't miss them!
0
4
16
I am hiring a research technician to help process and analyze multimodal neuroimaging data. Please RT!! * Great opportunity to gain research experience pre-PhD * Access to exciting data * Opportunities for independent projects Apply here: https://t.co/PT3kuBXHei
lu.varbi.com
Description of the workplace The research group for Neurodegenerative Research conducts research in dementia. Our research is focused on defining and understanding biological processes in Alzheimer’
2
56
75
We're thrilled to introduce our brand-new website: https://t.co/G5aPBUPApS! 🎉 Explore our cohorts, latest publications, news updates, team profiles, and so much more. Take a look!
biofinder.se
BioFINDER was initiated to discover key pathological mechanisms in Alzheimer's disease and other neurodegenerative diseases such as parkinsonian disorders. The generated knowledge will be used to...
0
5
19
Happy to share my first PhD publication out in @NatureComms! Hope this work will help improve CSF biomarker precision. Thanks to all co-authors and everyone involved in the Swedish BioFinder studies.
🚨New publication out in @NatureComms led by @karlssonlinda1! We introduce CSF reference proteins: a way to account for the non-disease related signal in CSF protein levels that varies between individuals and affects biomarker performance. https://t.co/E3Ph8sNCby Detailed 🧵👇
2
7
33
Spotorno et al. show that cortical mean diffusivity, a measure of cortical microstructure derived from diffusion MRI, can track disease progression on the AD continuum and could thus be a promising outcome measure in trials. https://t.co/yvReOMw4Qy;
https://t.co/TeRiD4mYhF
1
15
61
Happy to have been part of this review led by the great @JosephTherr! Here we discuss how biomarkers can help us to stage participants across the #Alzheimer's disease continuum and its applications. A good one to summarise the most recent developments in this fast-moving field.
Happy to share our new Review in @NatRevNeurol :) We describe advances in biomarker-based staging of AD, propose strategies for staging AD using fluid biomarkers, and outline how disease staging models inform the results of clinical trials. https://t.co/ozwhV5Kq8J
0
2
30
Hot off the press! Happy that this work lead by @HaBaumeister and myself is now published in Hippocampus: https://t.co/4aMyih6KWB Go check out some new figures!
onlinelibrary.wiley.com
The medial temporal lobe (MTL) cortex, located adjacent to the hippocampus, is crucial for memory and prone to the accumulation of certain neuropathologies such as Alzheimer's disease neurofibrilla...
New preprint from the HSG! 📢 https://t.co/UXchG4HNT4 This study led by @WuestefeldAnika and @HaBaumeister compared delineations of MTL cortex subregions made by four experts in three MTL specimens 🧠Here's a short summary of what we found 👇🧵 [1/x]
1
11
30
Hopefully this type of dMRI measure of cortical microstructure might turn out to be useful in clinical trials evaluating disease modifying therapies. Well done @NicolaSpotorno!
Spotorno et al. show that cortical mean diffusivity, a measure of cortical microstructure derived from diffusion MRI, is able to track disease progression on the AD continuum, and could thus be a promising outcome measure for clinical trials. https://t.co/DXQK0i0qwN
0
5
32
Being an @ISTAART Ambassador is a highly recommended experience for any trainee! Go sign up and find out more!
Interested in the ISTAART Ambassador Program? Join our virtual event on Jan 23, 2023, from 8:00 - 9:00 AM USA CT to connect with Ambassadors and ISTAART staff. Learn about the program's benefits, the application process, and get your queries answered! https://t.co/zoEgGlyTFr
0
0
5